Indication
Mucopolysaccharidosis Type 1
1 clinical trial
3 products
Clinical trial
A Phase III, Single Arm, Cross-over, Multicenter Clinical Trial to Compare Efficacy and Safety of P046 (Laronidase; CinnaGen) Versus Laronidase (Aldurazyme®; Genzyme, BioMarin) in Patients With Mucopolysaccharidosis Type I (MPS I)"Status: Completed, Estimated PCD: 2023-08-12
Product
AntihistamineProduct
AntipyreticProduct
Laronidase